Addressing Genomic Disparities in Cancer Survivors — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Addressing Genomic Disparities in Cancer Survivors — Stella

Home/Hereditary Cancer/

View on ClinicalTrials.gov

Recruiting

Back to Hereditary Cancer trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(2 sites)

United States

Georgetown Lombardi Comprehensive Cancer Center, Washington D.C., District of Columbia

Rutgers Cancer Institute, New Brunswick, New Jersey

Key details

Sponsor

Rutgers, The State University of New Jersey

Collaborators

Georgetown University, National Cancer Institute (NCI)

Enrollment target

~428 participants

Started

July 2024

Primary completion

December 2026

Age range

18 Years – 80 Years

Last updated October 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.